top
Please input keywords
Order
*Country
日本
アメリカ
中国
オーストラリア
シンガポール
イギリス
フランス
ドイツ
スイス
イタリア
カナダ
韓国
オランダ
ベルギー
スウェーデン
その他
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-Luc-EGFP MV-4-11
Common name

 B-Luc-EGFP MV-4-11

Catalog number    321856
Aliases

NA

Disease  Biphenotypic B myelomonocytic leukemia
Organism
Human Strain  NA
Tissue types

Peripheral blood

Tissue  Peripheral blood

Description

This B-Luc-EGFP MV-4-11 cell line expresses firefly luciferase as a marker of MV-4-11 cells. Luminescence could be detected in B-Luc-EGFP MV-4-11 cells.


Application


B-Luc-EGFP MV-4-11 cell line can be used to evaluate anti-cancer drugs in biphenotypic B myelomonocytic leukemia in vivo.


Targeting strategy

Gene targeting strategy for B-Luc-EGFP MV-4-11 cells. The exogenous promoter and luciferase-EGFP were inserted into the targeting vector used in the lentivirus system.


In vitro luciferase activity of B-Luc-EGFP MV-4-11 cells

from clipboard

Luminescence signal intensity of B-Luc-EGFP MV-4-11 cells. Luminescence intensity was measured using the Bright-GloTM luciferase Assay (Promega, Cat E2610). B-Luc-EGFP MV-4-11 cells have a strong luminescence signal. EGFP was detected in B-Luc-EGFP MV-4-11 cells. The 1-D02 clone of B-Luc-EGFP MV-4-11 cells can be used in vivo experiments.


Quantitative imaging data & body weight changes

from clipboard


Tumor growth and in vivo imaging of B-Luc-EGFP MV-4-11 cells. B-Luc-EGFP MV-4-11 cells (1x106) were injected into the tail vein of wild-type B-NDG mice. Signal intensity and body weight were measured twice a week. (A) Imaging was performed twice a week. (B) Body weight (Mean ± SEM). B-Luc-EGFP MV-4-11 cells can be used for in vivo efficacy evaluation.